These findings establish key targets (Bmp4, Serpine1, Ptgs2, Gata6) as central to SMA’s multisystem pathology, with TNF-α hyperactivation as the critical upstream driver [143]. This evidence concerns the gene GATA6 and proximal spinal muscular atrophy.